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Background: Pharmacist implemented transitions-of-care (TOC) programs focus on identifying
adherence issues, developing care plans, investigating medication-related insurance problems,
and instilling the value of medication treatment in patients frequently admitted to hospitals for
manageable, chronic disease-states.
Study objective: The primary objective of this study is to determine the impact of pharmacist
interventions during a TOC pilot on hospital readmission rates for patients with acute myocardial
infarction (AMI), heart failure (HF), chronic obstructive pulmonary disease (COPD), or
pneumonia.
Methods: This study is a retrospective review of patients receiving high intensity care to prevent
readmission, including pharmacy intervention during a three-month pilot period versus patients
with the same disease states not receiving high intensity care. The patient population includes
patients greater than 18 years of age who were admitted for AMI, HF, COPD, or pneumonia.
Patients were excluded if less than 18 years of age and prisoners.
Results: Hospital records identified 513 patients eligible for study inclusion following removal
of exclusion patients. The study showed no statistical evidence to conclude that pharmacy
intervention has effect on readmission rate when pharmacy intervention in the Medicare
population was compared to the non-pharmacy intervention Medicare population (Fisher’s Exact
P = 0.123).
Conclusion: The study failed to show a significant difference in readmissions for patients
receiving additional pharmacy care. Other factors play a role in readmission risk. Additional
studies including more patients and comparing risk factors for readmission are needed to
determine best practices to reduce risk while promoting patient health.
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Background
There is a trend of underutilization of pharmacists to provide intervention on medication
adherence for patients. Lack of adherence puts patients at increased risk for readmission, decline
in health, and morbidity and mortality. This also creates a greater burden on the health system as
hospitals are not reimbursed by government payors for readmissions within 30 days for certain
disease states. In an effort to prevent further readmissions, provide better quality of life, and
prevent reimbursement penalties, pharmacists are implementing transitions-of-care (TOC)
programs. These programs focus on identifying adherence issues, developing care plans,
investigating medication-related insurance problems, and instilling the value of medication
treatment in patients frequently admitted to hospitals for manageable, chronic disease-states.

In a study on the “Impact of a transition-of-care pharmacist during hospital discharge”,
pharmacists were involved in the education of 1,011 patients, performing 452 interventions
which lead to a decline in the overall readmissions per month (P = 0.0369).1 Interventions
included starting an omitted medication from previous admission, preventing discharge
problems, avoiding medication duplication, correcting medication-coverage insurance issues,
revising improper medication dose or quantity, changing inappropriate medications, and
resolving other problems pursuant to the patient’s medication. The findings indicated that a
transition-of-care pharmacist is in a unique position to educate patients, and resolve medication
errors and insurance problems which may result in reduced hospital readmission rates.

At New Hanover Regional Medical Center, a transitions of care protocol was implemented
through collaboration with a general medicine pharmacist, nurse and case manager.2 The
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discharge pilot focused on transitioning patients from inpatient to outpatient status with the
inpatient, general medicine pharmacist coordinating education and information with the
outpatient pharmacist. The baseline readmission rate for high-risk patients, those with high
readmission rates, chronic disease states, large number of medications, and psychosocial
concerns, to the general medicine floor was 17.88%. Following the pilot intervention,
readmission rates for these patients decreased to 15.31%. Those patients, with the general
medicine pharmacist-provided medication reconciliation and education, had a readmission of
14.67%. Furthermore, patients who elected to have their medications filled in the outpatient
pharmacy had a readmission rate of 9%. This study showed that pharmacist intervention may
have an impact on readmission rates by helping to streamline processes for better medication
adherence in high-risk patients.

With the implementation of the Affordable Care Act (ACA), further focus has been placed on
coordination of care and reducing unnecessary medical expenditure.4 In response to the act, the
Centers for Medicare and Medicaid Services (CMS) enacted cost-saving strategies to reduced
readmissions. CMS will not fully reimburse hospitals if patients with disease states such as acute
myocardial infarction (AMI), chronic heart failure, chronic obstructive pulmonary disease
(COPD), or pneumonia are readmitted within 30 days of discharge.

Eskenazi Health is dedicated to serving the unprivileged and thus serves a large portion of
Medicaid and Medicare patients in central Indiana.3 Financial stability is marked by the
cornerstone of receiving payment and reimbursement for medical services through CMS. Due to
the necessity and the concern for patients frequently readmitted, inpatient pharmacists have
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implemented a transitions-of-care (TOC) pilot which focuses on patients with a primary or
secondary diagnosis of AMI, HF, COPD, or pneumonia. The pharmacists implemented processes
to provide discharge medication reconciliation and discharge counseling, evaluation medication
adherence, accessibility, cost, insurance issues, and secure accessibility to medications upon
discharge to prevent hospital readmission.

Study Significance
The study attempts to show the impact of pharmacist intervention in transitioning patients from
hospital to home, and the potential impact of these interventions on reducing readmission rates in
patients who are at high risk for readmission.

Study Objective
The primary objective of this study is to determine the impact of pharmacist interventions during
the TOC pilot on hospital readmission rates for patients with AMI, HF, COPD, or pneumonia.
Secondary objectives include characterizing the pharmacist interventions, amount of time
dedicated to the pilot interventions, and patient adherence based on medication fill history.

Methods
Study Design
The study is a retrospective review of patients receiving high intensity care including pharmacy
intervention during a three month pilot period versus patients with the same disease states not
receiving high intensity care.

5

Study Data Source
The data source is through records obtained through electronic medical records at Eskenazi
Health.
Inclusion Criteria
The inclusion criteria for the study is patients greater than 18 years of age who have previous
admission for AMI, HF, COPD, or pneumonia
Exclusion Criteria
The exclusion criteria for the study is patients less than 18 years of age, prisoners, and patients
who did not have a diagnosis of AMI, HF, COPD, or pneumonia
Measurement of Variables
Measurement of variables include an analysis of readmission within 30-days post-discharge,
number of pharmacist interventions, time spent on interventions, pharmacy fill history postdischarge, number of medications post-discharge, and number of co-morbid conditions.
Control Variables
Control variables include readmission within 30-days post-discharge, pharmacy fill history postdischarge, number of medications post-discard, number of co-morbid conditions, and length of
stay while in hospital.
Statistical Analysis
Statistical analysis of the data is through a CHI square test, Fisher’s exact test, and Student T
test.
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Results & Discussion
Hospital records identified 513 patients eligible for study inclusion following removal of
exclusion patients. Baseline demographics (gender, age, race) are similar between the
intervention potential group overall (Medicare population) versus non-intervention group (other
insurance/no insurance population). COPD followed by mixed presentation, in which it was
undetermined which target disease state was the cause of readmission, are the highest causes for
admission in both groups. COPD is the highest cause of readmission in the pharmacy, Medicare
intervention group. Heart failure is the highest for readmission in the non-intervention, other
insurance/no insurance group. There were 13 patients readmitted within 30 days following
pharmacy intervention in the Medicare group (8 readmitted from the target disease in question),
compared to 62 in the non-pharmacy intervention Medicare group (25 from target disease) and
30 in the non-intervention, other insurance/no insurance group (5 from target disease). Table 1
summarizes the data below.

The results show that, per the CHI square test comparing all three test groups, differences seen
are not due to randomness (P < 0), but that there are no statistical differences between the
Medicare populations versus other insurance/no insurance study population (T test P = 0.617).
There is also no statistical evidence to conclude that pharmacy intervention has effect on
readmission rate when pharmacy intervention in the Medicare population was compared to the
non-pharmacy intervention Medicare population (Fisher’s Exact P = 0.123). It should be noted
that the pharmacy, Medicare-population intervention group consisted of only 46 patients of 237
possible. This can affect the variance of the statistical analysis and subjects it to high level of
factors not attributable solely to pharmacy intervention.
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Conclusion
Although pharmacist intervention is meant to reduce the risk of readmission through proper
counseling and management of medications, this study failed to show a significant difference in
readmissions for patients receiving additional pharmacy care. Other factors play a role in
readmission risk such as lack of adherence following education, health literacy issues, and
unavoidable readmissions (i.e. bone fractures). Additional studies including more patients and
comparing risk factors for readmission are needed to determine best practices to reduce risk
while promoting patient health.

Study Limitations
This study is limited to Eskenazi Health in Indianapolis, Indiana and includes patients with four
specific disease states—AMI, HF, COPD, or pneumonia. The study population does not include
any patient under the age of 18 years old, nor any prisoners who might otherwise fall into
inclusion criteria. These factors make this study less widely applicable to the general population.

The study only includes data from three month time period and is limited by number of
pharmacists able to participate in active interventions. The pilot study was conducted on patients
with Medicare Part D versus the control group that includes patients with other payers as well as
patients without insurance, and thus may contribute to other factors for readmission in the
control group not assessed by the study.
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Table 1. Descriptive statistics between groups
Intervention
Group –
Medicare Patient

Patient (n)
Males
Females
Mean age
Caucasian
African American
Other
Admission
diagnosis: Heart
Failure
Admission
diagnosis:
Myocardial
Infarction
Admission
diagnosis: COPD
Admission
diagnosis:
Pneumonia
Admission
diagnosis: Mixed
presentation
Mean length of
stay (days)
Median length of
stay (days)
Range
Mean number of
comorbid
conditions
Median number
of comorbid
conditions
Range

Non-intervention
– Other
Insurance/None
Medicare Patient
– No Pharmacy
Intervention

237
94
143
66.160
112
123
2
67

Medicare
Patient –
Pharmacy
Intervention
46
19
27
67.043
25
20
1
7

191
75
116
65.948
87
103
1
60

276
145
131
57.029
128
127
21
82

4

1

3

11

77

18

59

85

14

3

11

30

75

17

58

68

4.168

3.870

4.241

4.674

3

3

3

3

45-1
7.468

8-1
7.304

45-1
7.508

33-1
5.920

7

7

7

5

22-0

15-2

22-0

21-0
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Mean number of
medications at
admission
Median number
of medications at
admission
Range
Mean number of
medications at
discharge
Median number
of medications at
discharge
Number of
pharmacy
interventions
Mean time (min)
of pharmacy
intervention
Median time
(min) of
pharmacy
intervention
Mean number of
interventions
made
Median number
of interventions
made
Mean number of
interventions
accepted
Median number
of interventions
accepted
Claimed patient
pharmacy:
Eskenazi
Claimed patient
pharmacy: Other
Number of
patients utilizing
Eskenazi
outpatient
pharmacy

11.008

10.609

11.105

7.855

11

11

11

8

24-0
15.139

18-0
15.130

24-0
15.141

26-0
12.293

15

15

15

11.5

-

46

-

-

-

33.913

-

-

-

30

-

-

-

4.522

-

-

-

3

-

-

-

4.391

-

-

-

3

-

-

93

20

73

136

144

26

118

140

82

20

62

91
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Number of
patients utilizing
“Other”
pharmacies
Number of
patients with
confirmed fills
Mean number of
medications filled
at discharge
Median number
of medications
filled at discharge
Range
Number
readmitted within
30 days
Number
readmitted with
target disease
state
Readmission
diagnosis: HF
Readmission
diagnosis: MI
Readmission
diagnosis: COPD
Readmission
diagnosis:
Pneumonia
Readmission
diagnosis: Mixed
presentation

155

26

129

35

89

22

67

124

4.561

4.774

4.313

5.073

4

4

4

5

18-0
75

18-0
13

16-0
62

17-1
30

33

8

25

5

12

1

11

3

2

-

2

-

15

6

9

1

3

-

3

1

1

1

-

-
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